The first microRNA‐based anti‐cancer therapy is MRX34, a synthetic miR‐34a mimic that is loaded into liposomal nanoparticles,67 which acts as a tumour suppressor miRNA downstream of p53. The gene discussed is TP53; the disease is neoplasm.